Selected research
Market Structure
Global Armodafinil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Armodafinil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Armodafinil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Armodafinil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Armodafinil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Armodafinil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Armodafinil include Apotex, Aurobindo, Lupin, Natco Pharma, Mylan, Sandoz and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Armodafinil market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Armodafinil and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Armodafinil revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Armodafinil market size, projected growth trends, production technologies, key applications, and end-use industries.
Armodafinil Segment by Company
Apotex
Aurobindo
Lupin
Natco Pharma
Mylan
Sandoz
Teva
Armodafinil Segment by Type
50 mg Tablets
250 mg Tablets
200 mg Tablets
150 mg Tablets
Armodafinil Segment by Application
Obstructive Sleep Apnea (OSA) and Narcolepsy
Patients with Severe Hepatic Impairment
Shift Work Disorder (SWD)
Geriatric Patients
Armodafinil Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Armodafinil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Armodafinil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Armodafinil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Armodafinil in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Armodafinil industry.
Chapter 3: Detailed analysis of Armodafinil companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Armodafinilrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50 mg Tablets
- 250 mg Tablets
- 200 mg Tablets
- 150 mg Tablets
Applications
- Obstructive Sleep Apnea (OSA) and Narcolepsy
- Patients with Severe Hepatic Impairment
- Shift Work Disorder (SWD)
- Geriatric Patients
Companies covered
- Apotex
- Aurobindo
- Lupin
- Natco Pharma
- Mylan
- Sandoz
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Armodafinil Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 50 mg Tablets
- 1.2.3 250 mg Tablets
- 1.2.4 200 mg Tablets
- 1.2.5 150 mg Tablets
- 1.3 Market Analysis by Application
- 1.3.1 Global Armodafinil Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
- 1.3.3 Patients with Severe Hepatic Impairment
- 1.3.4 Shift Work Disorder (SWD)
- 1.3.5 Geriatric Patients
- 1.4 Global Market Growth Prospects
- 1.5 Global Armodafinil Growth Trends by Region
- 1.5.1 Global Armodafinil Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Armodafinil Market Size by Region (2021-2026)
- 1.5.3 Armodafinil Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Armodafinil Market Dynamics
- 2.1 Armodafinil Industry Trends
- 2.2 Armodafinil Industry Drivers
- 2.3 Armodafinil Industry Opportunities and Challenges
- 2.4 Armodafinil Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Armodafinil Revenue by Company (2021-2026)
- 3.2 Global Armodafinil Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Armodafinil Key Company Head office and Area Served
- 3.4 Global Armodafinil Company, Product Type & Application
- 3.5 Global Armodafinil Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Armodafinil Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Armodafinil Players Market Share by Revenue in 2025
- 3.6.3 2025 Armodafinil Tier 1, Tier 2, and Tier 3
4 Armodafinil Market by Type
- 4.1 Global Armodafinil Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Armodafinil Market Size by Type (2021-2032)
- 4.3 Global Armodafinil Market Size Share by Type (2021-2032)
5 Armodafinil Market by Application
- 5.1 Global Armodafinil Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Armodafinil Market Size by Application (2021-2032)
- 5.3 Global Armodafinil Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Apotex
- 6.1.1 Apotex Company Information
- 6.1.2 Apotex Business Overview
- 6.1.3 Apotex Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Apotex Armodafinil Product Portfolio
- 6.1.5 Apotex Recent Developments
- 6.2 Aurobindo
- 6.2.1 Aurobindo Company Information
- 6.2.2 Aurobindo Business Overview
- 6.2.3 Aurobindo Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Aurobindo Armodafinil Product Portfolio
- 6.2.5 Aurobindo Recent Developments
- 6.3 Lupin
- 6.3.1 Lupin Company Information
- 6.3.2 Lupin Business Overview
- 6.3.3 Lupin Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Lupin Armodafinil Product Portfolio
- 6.3.5 Lupin Recent Developments
- 6.4 Natco Pharma
- 6.4.1 Natco Pharma Company Information
- 6.4.2 Natco Pharma Business Overview
- 6.4.3 Natco Pharma Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Natco Pharma Armodafinil Product Portfolio
- 6.4.5 Natco Pharma Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Mylan Armodafinil Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Sandoz
- 6.6.1 Sandoz Company Information
- 6.6.2 Sandoz Business Overview
- 6.6.3 Sandoz Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Sandoz Armodafinil Product Portfolio
- 6.6.5 Sandoz Recent Developments
- 6.7 Teva
- 6.7.1 Teva Company Information
- 6.7.2 Teva Business Overview
- 6.7.3 Teva Armodafinil Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Teva Armodafinil Product Portfolio
- 6.7.5 Teva Recent Developments
7 North America
- 7.1 North America Armodafinil Market Size (2021-2032)
- 7.2 North America Armodafinil Market Size by Type
- 7.2.1 North America Armodafinil Market Size by Type (2021-2026)
- 7.2.2 North America Armodafinil Market Size by Type (2027-2032)
- 7.2.3 North America Armodafinil Market Share by Type (2021-2032)
- 7.3 North America Armodafinil Market Size by Application
- 7.3.1 North America Armodafinil Market Size by Application (2021-2026)
- 7.3.2 North America Armodafinil Market Size by Application (2027-2032)
- 7.3.3 North America Armodafinil Market Share by Application (2021-2032)
- 7.4 North America Armodafinil Market Size by Country
- 7.4.1 North America Armodafinil Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Armodafinil Market Size by Country (2021-2026)
- 7.4.3 North America Armodafinil Market Size by Country (2027-2032)
- 7.4.4 North America Armodafinil Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Armodafinil Market Size (2021-2032)
- 8.2 Europe Armodafinil Market Size by Type
- 8.2.1 Europe Armodafinil Market Size by Type (2021-2026)
- 8.2.2 Europe Armodafinil Market Size by Type (2027-2032)
- 8.2.3 Europe Armodafinil Market Share by Type (2021-2032)
- 8.3 Europe Armodafinil Market Size by Application
- 8.3.1 Europe Armodafinil Market Size by Application (2021-2026)
- 8.3.2 Europe Armodafinil Market Size by Application (2027-2032)
- 8.3.3 Europe Armodafinil Market Share by Application (2021-2032)
- 8.4 Europe Armodafinil Market Size by Country
- 8.4.1 Europe Armodafinil Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Armodafinil Market Size by Country (2021-2026)
- 8.4.3 Europe Armodafinil Market Size by Country (2027-2032)
- 8.4.4 Europe Armodafinil Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Armodafinil Market Size (2021-2032)
- 9.2 China Armodafinil Market Size by Type
- 9.2.1 China Armodafinil Market Size by Type (2021-2026)
- 9.2.2 China Armodafinil Market Size by Type (2027-2032)
- 9.2.3 China Armodafinil Market Share by Type (2021-2032)
- 9.3 China Armodafinil Market Size by Application
- 9.3.1 China Armodafinil Market Size by Application (2021-2026)
- 9.3.2 China Armodafinil Market Size by Application (2027-2032)
- 9.3.3 China Armodafinil Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Armodafinil Market Size (2021-2032)
- 10.2 Asia Armodafinil Market Size by Type
- 10.2.1 Asia Armodafinil Market Size by Type (2021-2026)
- 10.2.2 Asia Armodafinil Market Size by Type (2027-2032)
- 10.2.3 Asia Armodafinil Market Share by Type (2021-2032)
- 10.3 Asia Armodafinil Market Size by Application
- 10.3.1 Asia Armodafinil Market Size by Application (2021-2026)
- 10.3.2 Asia Armodafinil Market Size by Application (2027-2032)
- 10.3.3 Asia Armodafinil Market Share by Application (2021-2032)
- 10.4 Asia Armodafinil Market Size by Country
- 10.4.1 Asia Armodafinil Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Armodafinil Market Size by Country (2021-2026)
- 10.4.3 Asia Armodafinil Market Size by Country (2027-2032)
- 10.4.4 Asia Armodafinil Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Armodafinil Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Armodafinil Market Size by Type
- 11.2.1 South America, Middle East & Africa Armodafinil Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Armodafinil Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Armodafinil Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Armodafinil Market Size by Application
- 11.3.1 South America, Middle East & Africa Armodafinil Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Armodafinil Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Armodafinil Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Armodafinil Market Size by Country
- 11.4.1 South America, Middle East & Africa Armodafinil Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Armodafinil Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Armodafinil Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Armodafinil Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst